Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102050791B discloses a cost-effective synthesis of telmisartan intermediates using mild conditions, offering supply chain stability and reduced production costs for global manufacturers.
Patent CN109503568A details a high-yield Dasatinib synthesis using ionic liquids and copper catalysis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN106749259B reveals a metal-free synthetic route for CDK4/6 inhibitor intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN102264672A details a scalable route to chiral phenols using Ru-catalyzed transfer hydrogenation, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN1222537C reveals a novel Fmoc-strategy for Eptifibatide synthesis, eliminating toxic HF and reducing cycle time. Ideal for reliable peptide intermediate sourcing.
Patent CN1246308C reveals a mild acid-catalyzed route for beta-hydroxy sulfone derivatives. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity intermediates.
Patent CN115613061A reveals a green electro-catalytic method for azide-substituted tetrazolo[1,5-a]indole synthesis, offering cost-effective scale-up for pharmaceutical intermediates.
Patent CN111138325A reveals a safe, copper-catalyzed route to tetra-substituted Z-beta-sulfonyl enamines using solid SO2 sources, offering reliable pharmaceutical intermediate supply.
Patent CN116444503A details a rhodium-catalyzed route to chroman derivatives using pyridine triazoles, offering mild conditions and high purity for pharmaceutical manufacturing.
Patent CN115974758A reveals safe iridium-catalyzed synthesis avoiding diazo compounds. Delivers cost reduction in pharmaceutical intermediate manufacturing with superior scalability.
Novel 5-step route from o-nitrotoluene offers cost-effective production of high-purity o-aminophenylpropanol, avoiding high-pressure hydrogenation equipment.
Patent CN119638592A discloses a novel route for semaglutide side chain. Achieve high purity and reduced emulsification risks for scalable GLP-1 manufacturing.
Patent CN109369672B reveals a rapid room-temperature synthesis of cycloheptatriene derivatives using PIDA, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113292393A reveals a mild SmI2-catalyzed reductive deuteration of acyl fluorides. This method offers high deuterium incorporation and superior chemoselectivity for manufacturing deuterated pharmaceutical intermediates.
Novel solvent-free method for acyl ferrocene hydrazinodithioformate Schiff base. High yield, green chemistry, cost-effective manufacturing for pharma intermediates.
Patent CN108299303A reveals metal-free tetraarylpyrazole synthesis. Offers high yield, cost reduction in pharmaceutical intermediates manufacturing, and reliable supply chain scalability.
Patent CN112824421A reveals a robust chiral ligand synthesis route offering high enantioselectivity and TON up to 10000 for pharmaceutical manufacturing.
Novel catalytic route for benzofuran-2(3H)-one reduces steps and costs. Ideal for azoxystrobin production. High purity pharma intermediates available.
Patent CN1824646A details a green synthesis of aryl-substituted quinones in water. This method offers high yields and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN111440205B reveals a novel diboronic acid diol ester enabling high-yield, 99% ee chiral 1,2-diamine synthesis with recyclable reagents for cost-effective manufacturing.